<DOC>
	<DOCNO>NCT02030418</DOCNO>
	<brief_summary>Prospective , non-randomized , single-arm , international multicenter , clinical safety effectiveness leadless pacemaker system patient indicate VVIR pacemaker . Following completion enrollment IDE , patient continue enrol continued access phase study protocol .</brief_summary>
	<brief_title>The LEADLESS Pacemaker IDE Study ( Leadless II )</brief_title>
	<detailed_description>The purpose study evaluate safety effectiveness leadless pacemaker system treat patient slow heart rate irregular heartbeat . The Nanostim leadless pacemaker provide bradycardia pace pulse generator built-in battery electrode , permanent implantation right ventricle . As leadless pacemaker , need connector , pace lead , pulse generator pocket , operate principle conventional pacemaker .</detailed_description>
	<mesh_term>Bradycardia</mesh_term>
	<criteria>1 . Subject must one clinical indication device implant adherence Medicare , ACC/AHA/HRS/ESC single chamber pace guideline include : Chronic and/or permanent atrial fibrillation 2 3° AV bifascicular bundle branch block ( BBB block ) , include slow ventricular rate ( without medication ) associate atrial fibrillation ; Normal sinus rhythm 2 3° AV BBB block low level physical activity short expect lifespan ( least one year ) ; Sinus bradycardia infrequent pause unexplained syncope EP finding ; 2 . Subject ≥18 year age ; 3 . Subject life expectancy least one year ; 4 . Subject enrol another clinical investigation ; 5 . Subject willing comply clinical investigation procedure agree return require followup visit , test , exam ; 6 . Subject informed nature study , agree provision provide write informed consent , approve IRB ; 7 . Subject pregnant plan get pregnant course study . 1 . Subject pacemaker syndrome , retrograde VA conduction suffers drop arterial blood pressure onset ventricular pacing ; 2 . Subject allergic hypersensitive &lt; 1 mg dexamethasone sodium phosphate ; 3 . Subject mechanical tricuspid valve prosthesis ; 4 . Subject preexist endocardial pace defibrillation lead ; 5 . Subject current implantation either conventional subcutaneous implantable cardioverter defibrillator ( ICD ) cardiac resynchronization therapy ( CRT ) ; 6 . Subject implanted vena cava filter ; 7 . Subject evidence thrombosis one vein use access procedure ; 8 . Subject implanted leadless cardiac pacemaker ; 9 . Subject recent cardiovascular peripheral vascular surgery within 30 day enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>